 This study is designed to evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of combination treatment with Temodar, Genasense, and Abraxane in chemotherapy-naïve subjects with advanced melanoma and normal lactate dehydrogenase LDH. 